A drug with the SMILES Cn1c2c(c(=O)n(C)c1=O)C(c1ccccc1OC(F)F)C1=C(CCCC1=O)N2 has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 1.997\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
Cn1c2c(c(=O)n(C)c1=O)C(c1ccccc1OC(F)F)C1=C(CCCC1=O)N2
Cn1c2c(c(=O)n(C)c1=O)C(c1ccccc1OC(F)F)C1=C(CCCC1=O)N2
5-[2-(difluoromethoxy)phenyl]-1,3-dimethyl-7,8,9,10-tetrahydro-5H-pyrimido[4,5-b]quinoline-2,4,6-trione